Digital A Plus to host 1st Asia Pacific Multichannel Marketing Expert Meeting for Pharma and Healthcare in Kuala Lumpur
Author(s): City Air NewsBangalore: Digital A Plus Group of Companies (Digital A Plus Healthcare Malaysia, Digi A Plus Technologies Shanghai, and DAP E-nnovative Solutions India) a leading provider of digital and medical communication solutions...
Bangalore: Digital A Plus Group of Companies (Digital A Plus Healthcare Malaysia, Digi A Plus Technologies Shanghai, and DAP E-nnovative Solutions India) a leading provider of digital and medical communication solutions to top Global Life Science & Bio Pharmaceutical Companies globally will be hosting 1st Asia Pacific Multichannel Marketing Expert Meeting for Pharma and Healthcare on Friday, May 19th 2017, at Aloft KL Sentral, Kuala Lumpur, Malaysia. The event will have an audience of around 120 delegates from the industry who will offer their insights on the theme ‘Reshaping the future of Pharma’.
The goal of the event is to bring together the bright and innovative minds of the industry to share ideas and experiences that foster learning, inspiration and wonder in the field of multichannel marketing. Nataliya Andreychuk, CEO at Viseven Europe OÜ, CLM expert will be addressing the audience as the keynote speaker. Ms. Andreychuk is a leading expert in digital pharma marketing and CLM implementation and will be speaking on the topic ‘Embedding Digital into Corporate DNA – digital as part of the Multichannel Mix and integrated strategy for 2017’.
Sylvia Hii, Founder & VP – Marketing, Digital A Plus Group of Companies said, “The Digital health movement will transform the way we define healthcare and how pharma companies will engage its consumers. The revolution of digital communication is going to drive the future commercial model pharma companies, allowing for more flexibility and increased customer touch points. The digital age has paved the way, sprouting up new communication channels with healthcare professionals and this meet serves as a platform to encourage all the industry players to work in tandem to reshape the future of pharma.”